Published in J Cell Mol Med on March 27, 2015
PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway. Oncotarget (2016) 0.75
GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF. Oncotarget (2017) 0.75
The Clathrin-dependent Spindle Proteome. Mol Cell Proteomics (2016) 0.75
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med (2005) 12.18
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science (1994) 10.45
Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell (2003) 3.42
Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol (2004) 3.26
Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell (2004) 2.72
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol (2005) 2.55
Nucleolar protein B23 has molecular chaperone activities. Protein Sci (1999) 2.07
The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood (1996) 1.98
Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. Oncogene (2011) 1.79
The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene (1996) 1.65
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med (2011) 1.52
Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol (1996) 1.36
Identification and characterization of a hexameric form of nucleolar phosphoprotein B23. Biochim Biophys Acta (1987) 1.33
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. Haematologica (2007) 1.30
Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity. Mol Cell Biol (2008) 1.30
Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res (1992) 1.24
Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J Biol Chem (2004) 1.23
Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation. Mol Biol Cell (2006) 1.21
Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate (1999) 1.20
The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death. Cell Death Differ (2007) 1.18
Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability. J Biol Chem (2006) 1.13
NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene (2008) 1.11
Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig (1998) 1.10
Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma. Mol Pathol (2000) 1.07
DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer. J Mol Histol (2006) 1.05
Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas. J Pathol (2008) 1.05
DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway. Cancer Res (2008) 1.04
Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells. Biochim Biophys Acta (1995) 0.98
Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer. BMC Cancer (2009) 0.94
Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis. Cancer Biol Ther (2005) 0.93
Reduced numatrin/B23/nucleophosmin labeling in apoptotic Jurkat T-lymphoblasts. J Biol Chem (1995) 0.92
Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses. Cell Death Differ (2012) 0.92
Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation. Cancer Res (2010) 0.91
Regulation of p14ARF through subnuclear compartmentalization. Cell Cycle (2006) 0.90
Involvement of GLTSCR2 in the DNA Damage Response. Am J Pathol (2011) 0.90
TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice. Blood (2008) 0.89
Oncogenic role of nucleophosmin/B23. Chang Gung Med J (2007) 0.88
The expression of GLTSCR2, a candidate tumor suppressor, is reduced in seborrheic keratosis compared to normal skin. Pathol Res Pract (2010) 0.87